Fetal Intraperitoneal Immunoglobulin for Autoimmune Myocarditis and AV Block
This case series demonstrates the feasibility and potential safety of IPIG as a novel fetal immunomodulatory therapy. Although outcomes were encouraging, efficacy cannot be established without larger comparative studies.
Authors
- Shweta Bakhru (ORCID: https://orcid.org/0000-0002-4409-2301)
- Nageswara Rao Koneti (ORCID: https://orcid.org/0000-0001-5403-8870)
- Bhargavi Dhulipudi
Institutions
- Rainbow Children's Hospital (IN)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106489
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00